These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort. Adamou R, Dechavanne C, Sadissou I, d'Almeida T, Bouraima A, Sonon P, Amoussa R, Cottrell G, Le Port A, Theisen M, Remarque EJ, Longacre S, Moutairou K, Massougbodji A, Luty AJF, Nuel G, Migot-Nabias F, Sanni A, Garcia A, Milet J, Courtin D. Malar J; 2019 Jun 11; 18(1):194. PubMed ID: 31185998 [Abstract] [Full Text] [Related]
3. Evaluation of host humoral antibody production against Plasmodium falciparum recombinant circumsporozoite antigen in Nigerian children. Oluwasogo OA, Ebenezer OO, Chiaka A. J Vector Borne Dis; 2012 Sep 11; 49(3):151-6. PubMed ID: 23135009 [Abstract] [Full Text] [Related]
4. IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. Taylor RR, Allen SJ, Greenwood BM, Riley EM. Am J Trop Med Hyg; 1998 Apr 11; 58(4):406-13. PubMed ID: 9574783 [Abstract] [Full Text] [Related]
5. Humoral immune response to Plasmodium falciparum vaccine candidate GMZ2 and its components in populations naturally exposed to seasonal malaria in Ethiopia. Mamo H, Esen M, Ajua A, Theisen M, Mordmüller B, Petros B. Malar J; 2013 Feb 05; 12():51. PubMed ID: 23383869 [Abstract] [Full Text] [Related]
6. Effect of transmission intensity and age on subclass antibody responses to Plasmodium falciparum pre-erythrocytic and blood-stage antigens. Noland GS, Jansen P, Vulule JM, Park GS, Ondigo BN, Kazura JW, Moormann AM, John CC. Acta Trop; 2015 Feb 05; 142():47-56. PubMed ID: 25446174 [Abstract] [Full Text] [Related]
7. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria. Perraut R, Varela ML, Joos C, Diouf B, Sokhna C, Mbengue B, Tall A, Loucoubar C, Touré A, Mercereau-Puijalon O. Vaccine; 2017 Dec 04; 35(48 Pt B):6720-6726. PubMed ID: 29042203 [Abstract] [Full Text] [Related]
9. Cytophilic antibodies to Plasmodium falciparum glutamate rich protein are associated with malaria protection in an area of holoendemic transmission. Lusingu JP, Vestergaard LS, Alifrangis M, Mmbando BP, Theisen M, Kitua AY, Lemnge MM, Theander TG. Malar J; 2005 Sep 29; 4():48. PubMed ID: 16194274 [Abstract] [Full Text] [Related]
10. Pattern of humoral immune response to Plasmodium falciparum blood stages in individuals presenting different clinical expressions of malaria. Leoratti FM, Durlacher RR, Lacerda MV, Alecrim MG, Ferreira AW, Sanchez MC, Moraes SL. Malar J; 2008 Sep 24; 7():186. PubMed ID: 18816374 [Abstract] [Full Text] [Related]
11. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness. Stanisic DI, Richards JS, McCallum FJ, Michon P, King CL, Schoepflin S, Gilson PR, Murphy VJ, Anders RF, Mueller I, Beeson JG. Infect Immun; 2009 Mar 24; 77(3):1165-74. PubMed ID: 19139189 [Abstract] [Full Text] [Related]
12. Age-dependent antibody response to Plasmodium falciparum merozoite surface protein 2 (MSP-2). Khosravi A, Hommel M, Sayemiri K. Parasite Immunol; 2011 Mar 24; 33(3):145-57. PubMed ID: 21306398 [Abstract] [Full Text] [Related]
13. Pattern of antibodies to the Duffy binding like domain of Plasmodium falciparum antigen Pf332 in Senegalese individuals. Balogun HA, Awah N, Nilsson S, Rogier C, Trape JF, Chen Q, Roussilhon C, Berzins K. Acta Trop; 2014 Feb 24; 130():80-7. PubMed ID: 24200839 [Abstract] [Full Text] [Related]
14. Epidemiology of malaria in an area prepared for clinical trials in Korogwe, north-eastern Tanzania. Mmbando BP, Segeja MD, Msangeni HA, Sembuche SH, Ishengoma DS, Seth MD, Francis F, Rutta AS, Kamugisha ML, Lemnge MM. Malar J; 2009 Jul 18; 8():165. PubMed ID: 19615093 [Abstract] [Full Text] [Related]
15. Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response. Stanisic DI, Fowkes FJ, Koinari M, Javati S, Lin E, Kiniboro B, Richards JS, Robinson LJ, Schofield L, Kazura JW, King CL, Zimmerman P, Felger I, Siba PM, Mueller I, Beeson JG. Infect Immun; 2015 Feb 18; 83(2):646-60. PubMed ID: 25422270 [Abstract] [Full Text] [Related]
16. [Specific antibodies to Plasmodium falciparum antigens in immune patients: IV--Cross-sectional analysis of anti-P. falciparum Ab responses in a mesoendemic zone of transmission in Sine-Saloum region]. Sidibé S, Diouf B, Tall A, Spiegel A, Trape JF, Garraud O, Dièye A, Perraut P. Dakar Med; 2000 Feb 18; 45(2):117-21. PubMed ID: 15779164 [Abstract] [Full Text] [Related]
17. Subclass responses and their half-lives for antibodies against EBA175 and PfRh2 in naturally acquired immunity against Plasmodium falciparum malaria. Ahmed Ismail H, Tijani MK, Langer C, Reiling L, White MT, Beeson JG, Wahlgren M, Nwuba R, Persson KE. Malar J; 2014 Nov 05; 13():425. PubMed ID: 25373511 [Abstract] [Full Text] [Related]
19. Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa. Nebie I, Diarra A, Ouedraogo A, Soulama I, Bougouma EC, Tiono AB, Konate AT, Chilengi R, Theisen M, Dodoo D, Remarque E, Bosomprah S, Milligan P, Sirima SB. Infect Immun; 2008 Feb 05; 76(2):759-66. PubMed ID: 18070896 [Abstract] [Full Text] [Related]